Heart valve tissue engineering: Concepts, approaches, progress, and challenges

Annals of Biomedical Engineering

Volumn 34, Issue 12, 2006, Pages 1799-1819

  Mendelson, Karen ^a   Schoen, Frederick J ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Biodegradable scaffold; Circulating stem cells; Decellularized scaffold; Engineered tissue heart valves; Heart valve remodeling

Indexed keywords

ARTIFICIAL ORGANS; BIODEGRADATION; BIOMECHANICS; CELLS; PRODUCT DEVELOPMENT; SCAFFOLDS; TISSUE; TRANSPLANTATION (SURGICAL);

BIODEGRADABLE SCAFFOLDS; CIRCULATING STEM CELLS; DECELLULARIZED SCAFFOLDS; ENGINEERED TISSUE HEART VALVES; HEART VALVE REMODELING;

BIOMEDICAL ENGINEERING;

ANIMAL; BIOARTIFICIAL ORGAN; BIOPROSTHESIS; HEART VALVE; HEART VALVE PROSTHESIS; HUMAN; METHODOLOGY; PATHOLOGY; REVIEW; TISSUE ENGINEERING; VALVULAR HEART DISEASE;

ANIMALS; BIOARTIFICIAL ORGANS; BIOPROSTHESIS; HEART VALVE DISEASES; HEART VALVE PROSTHESIS; HEART VALVES; HUMANS; TISSUE ENGINEERING;

EID: 33751103663     PISSN: 00906964     EISSN: 15739686     Source Type: Journal    
DOI: 10.1007/s10439-006-9163-z     Document Type: Article

References (188)

1. Aikawa, E., P. Whittaker, M. Farber, K. Mendelson, R. Padera, and F. Schoen. Human semilimar cardiac valve remodeling by activated cells from fetus to adult: Implications for postnatal adaptation, valve pathology and tissue engineering. Circulation 113:1344-1352, 2006.
2. Anderson, D. G., J. A. Burdick, and R. Langer. Materials science. Smart biomaterials. Science 305:1923-1924, 2004.
3. Aoki, J., P. W. Serruys, H. van Beusekom, A. T. Ong, E. P. McFadden, G. Sianos, W. J. van der Giessen, E. Regar, P. J. de Feyter, H. R. Davis, S. Rowland, and M. J. Kutryk. Endothelial progenitor cell capture by stents coated with antibody against CD34: the HEALING-FIM (Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth-First In Man) Registry. J. Am. Coll. Cardiol. 45:1574-1579, 2005.
4. Apple, F. S., A. H. Wu, J. Mair, J. Ravkilde, M. Panteghini, J. Tate, F. Pagani, R. H. Christenson, M. Mockel, O. Danne, A. S. Jaffe, and the Committee on Standardization of Markers of Cardiac Damage of the IFCC. Future biomarkers for detection of ischemia and risk stratification in acute coronary syndrome. Clin. Chem. 51:810-824, 2005.
5. Armstrong, E. J., and J. Bischoff. Heart valve development: Endothelial cell signaling and differentiation. Circ. Res. 95:459-470, 2004.
6. Badylak, S. F. Regenerative medicine approach to heart valve replacement. Circulation 111:2715-2716, 2005.
7. Badylak, S. F., R. Record, K. Lindberg, J. Hodde, and K. Park. Small intestinal submucosa: a substrate for in vitro cell growth. J. Biomater. Sci. Polym. 9:863-878, 1998.
8. Basilion, J. P., S. Yeon, and R. Botnar. Magnetic resonance imaging: utility as a molecular imaging modality. Curr. Top Dev. Biol. 70:1-33, 2005.
9. Beis, D., T. Bartman, S. W. Jin, I. C. Scott, L. A. D'Amico, E. A. Ober, H. Verkade, J. Frantsve, H. A. Field, A. Wehman, H. Baier, A. Tallafuss, L. Bally-Cuif, J. N. Chen, D. Y. Stainier, and B. Jungblut. Genetic and cellular analyses of zebrafish atrioventricular cushion and valve development. Development 132:4193-4204, 2005.
10. Bertipaglia, B., F. Ortolani, L. Petrelli, G. Gerosa, M. Spina, P. Pauletto, D. Casarotto, M. Marchini, and S. Sartore. Vitalitate Exornatum Succedaneum Aorticum Labore Ingenioso Obtenibitur Project. Cell characterization of porcine aortic valve and decellularized leaflets repopulated with aortic valve interstitial cells: the VESALIO Project (Vitalitate Exornatum Succedaneum Aorticum Labore Ingenioso Obtenibitur). Ann. Thorac. Surg. 75:1274-1282, 2003.
11. Blom, I. E., A. J. van Dijk, R. A. de Weger, M. G. Tilanus, and R. Goldschmeding. Identification of human ccn2 (connective tissue growth factor) promoter polymorphisms. Mol. Pathol. 54:192-196, 2001.
12. Boecker, W., O. Y. Bernecker, J. C. Wu, X. Zhu, T. Sawa, L. Grazette, A. Rosenzweig, F. del Monte, U. Schmidt, and R. J. Hajjar. Cardiac-specific gene expression facilitated by an enhanced myosin light chain promoter. Mol. Imaging 3:69-75, 2004.
13. Borschel, G. H., Y. C. Huang, S. Calve, E. M. Arruda, J. B. Lynch, D. E. Dow, W. M. Kuzon, R. G. Dennis, and D. L. Brown. Tissue engineering of recellularized small-diameter vascular grafts. Tissue Eng. 11:778-786, 2005.
14. Breuer, C. K., B. A. Mettler, T. Anthony, V. L. Sales, F. J. Schoen, J. E. Mayer. Application of tissue-engineering principles toward the development of a semilunar heart valve substitute. Tissue Eng. 10:1725-1736, 2004.
15. Brezinski, M. E. Optical coherence tomography for identifying unstable coronary plaque. Int. J. Cardiol. 107:159-170, 2006.
16. Butcher, J. T., and R. M. Nerem. Porcine aortic valve interstitial cells in three-dimensional culture: comparison of phenotype with aortic smooth muscle cells. J. Heart Valve Dis. 13:478-485, 2004.
17. Butcher, J. T., A. M. Penrod, A. J. Garcia, and R. M. Nerem. Unique morphology and focal adhesion development of valvular endothelial cells in static and fluid flow environments. Arterioscler. Thromb. Vasc. Biol 24:1429-1434, 2004.
18. Ceradini, D. J., and G. C. Gurtner. Homing to hypoxia: HIF-1 as a mediator of progenitor cell recruitment to injured tissue. Trends Cardiovasc Med. 15:57-63, 2005.
19. Chen, J., C. H. Tung, U. Mahmood, V. Ntziachristos, R. Gyurko, M. C. Fishman, P. L. Huang, and R. Weissleder. In-vivo imaging of proteolytic activity in atherosclerosis. Circulation 105:2766-2771, 2002.
20. Courtney, T., M. S. Sacks, J. Stankus, J. Guan, and W. R. Wagner. Analysis and design of tissue engineered scaffolds that mimic soft tissue mechanical anisotropy. Biomat. 27:3631-3638, 2006.
21. Davies, P. F., A. G. Passerini, and C. A. Simmons. Aortic valve: turning over a new leaf(let) in endothelial phenotypic heterogeneity. Arterioscler Thromb. Vasc. Biol. 24:1331-1333, 2004.
22. Dawn, B., and R. Bolli. Adult bone marrow-derived cells: Regenerative potential, plasticity, and tissue commitment. Basic Res. Cardiol. 100:494-503, 2005.
23. Deb, A., S. H. Wang, K. Skelding, D. Miller, D. Simper, and N. Caplice. Bone marrow-derived myofibroblasts are present in adult human heart valves. J. Heart Valve Dis. 14:674-678, 2005.
24. Deguchi, J.-O., E. Aikawa, P. Libby, J. R. Vachon, M. Inada, S. M. Krane, P. Whittaker, and M. Aikawa. Matrix metalloproteinase-13/collagenase-3 deletion promotes collagen accumulation and organization in mouse atherosclerotic plaques. Circulation 112:2708-2715, 2005.
25. Della Rocca, F., S. Sartore, D. Guidolin, B. Bertiplaglia, G. Gerosa, D. Casarotto, and P. Pauletto. Cell composition of the human pulmonary valve: A comparative study with the aortic valve-The VESALIO project. Ann. Thorac. Surg. 70:1594-1600, 2000.
26. Deutsch, M., J. Meinhart, T. Fischlein, P. Preiss, and P. Zilla. Clinical autologous in vitro endothelialization of infrainguinal ePTFE grafts in 100 patients: a 9-year experience. Surgery 126:847-855, 1999.
27. Dimmeler, S., A. M. Zeiher, and M. D. Schneider. Unchain my heart: the scientific foundations of cardiac repair. J. Clin. Invest 115:572-583, 2005.
28. Dohmen, P. M., F. Costa, S. V. Lopes, S. Yoshi, F. P. Souza, R. Vilani, M. B. Costa, and W. Konertz. Results of a decellularized porcine heart valve implanted into the juvenile sheep model. Heart Surg. Forum. 8:E100-E104, 2005.
29. Dohmen, P. M., A. Lembcke, H. Hotz, D. Kivelitz, and W. F. Konertz. Ross operation with a tissue-engineered heart valve. Ann. Thorac. Surg. 74:1438-1442, 2002.
30. Eisenberg, L. M., and R. R. Markwald. Molecular regulation of atrioventricular valvuloseptal morphogenesis. Circ. Res. 77:1-6, 1995.
31. Eisenberg, L. M., R. Moreno, and R. R. Markwald. Multiple stem cell populations contribute to the formation of the myocardium. Ann. N.Y. Acad. Sci. 1047:38-49, 2005.
32. Elkins, R. C., P. E. Dawson, S. Goldstein, S. P. Walsh, and K. S. Black. Decellularized human valve allografts. Ann. Thorac. Surg. 71:S428-S432, 2001.
33. Emsley, J. G., B. D. Mitchell, G. Kempermann, and J. D. Macklis. Adult neurogenesis and repair of the adult CNS with neural progenitors, and stem cells. Prog. Neurobiol. 75:321-341, 2005.
34. Engelmayr, G. C., D. K. Hildebrand, F. W. Sutherland, J. E. Mayer, and M. S. Sacks. A novel bioreactor for the dynamic flexural stimulation of tissue engineered heart valve biomaterials. Biomaterials 24:2523-2532, 2003.
35. Erez, E., K. R. Kanter, E. Isom, W. H. Williams, and V. K. Tam. Mitral valve replacement in children. J. Heart Valve Dis. 12:25-29, 2003.
36. Eschenhagen, T., and W. H. Zimmermann. Engineering myocardial tissue. Circ. Res. 97:1220-1231, 2005.
37. Eybl, E., M. Grimm, M. Grabenwoger, P. Bock, M. M. Muller, and E. Wolner. Endothelial cell lining of bioprosthetic heart valve materials. J. Thorac. Cardiovasc. Surg. 104:763-769, 1992.
38. Fedak, P. W. M., D. S. Smookler, Z. Kassiri, N. Ohno, K. J. Leco, S. Verma, D. A. G. Mickle, K. L. Watson, C. V. Hojilla, W. Cruz, R. D. Weisel, R.-K. Li, and R. Khokha. TIMP-3 deficiency leads to dilated cardiomyopathy. Circulation 110:2401-2409, 2004.
39. Fernandez, C. A., L. Yan, G. Louis, J. Yang, J. L. Kutok, and M. A. Moses. The matrix metalloproteinase-9/neutrophil gelatinase-associated lipocalin complex plays a role in breast tumor growth and is present in the urine of breast cancer patients. Clin. Cancer Res. 11:5390-5395, 2005.
40. Frazier, O. H., R. T. Baldwin, S. G. Eskin, and J. M. Duncan. Immunochemical identification of human endothelial cells on the lining of a ventricular assist device. Tex Heart Inst. J. 20:78-82, 1993.
41. Freed, L. E., G. Vunjak-Novakovic, R. J. Biron, D. B. Eagles, D. C. Lesnoy, S. K. Barlow, and R. Langer. Biodegradable polymer scaffolds for tissue engineering. Biotechnology 12:689-693, 1994.
42. Fukuda, D., K. Shimada, A. Tanaka, T. Kusuyama, H. Yamashita, S. Ehara, Y. Nakamura, T. Kawarabayashi, H. Iida, M. Yoshiyama, and J. Yoshikawa. Comparison of levels of serum matrix metalloproteinase-9 in patients with acute myocardial infarction versus unstable angina pectoris versus stable angina pectoris. Am. J. Cardiol. 97:175-180, 2006.
43. Garg, V., A. N. Muth, J. F. Ransom, M. K. Schluterman, R. Barnes, I. N. King, P. D. Grossfeld, and D. Srivastava. Mutations in NOTCH1 cause aortic valve disease. Nature 437:270-274, 2005.
44. Genove, G., U. DeMarco, H. Xu, W. F. Goins, and E. T. Ahrens. A new transgene reporter for in vivo magnetic resonance imaging. Nat. Med. 11:450-454, 2005.
45. George, J., A. Afek, A. Abashidze, H. Shmilovich, V. Deutsch, J. Kopolovich, H. Miller, and G. Keren. Transfer of endothelial progenitor and bone marrow cells influences atherosclerotic plaque size and composition in Apolipoprotein E knockout mice. Arterioscler. Thromb. Vasc. Biol. 25:2636-2641, 2005.
46. Giannoudis, P. V., and I. Pountos. Tissue regeneration: The past, the present and the future. Injury 36(Suppl.):S2-S5, 2005.
47. Giattina, S. D., B. K. Courtney, P. R. Herz, M. Harman, S. Shortkroff, D. L. Stamper, B. Liu, J. G. Fujimoto, and M. E. Brezinski. Assessment of coronary plaque collagen with polarization sensitive optical coherence tomography (PS-OCT). Int. J. Cardiol. 107:400-409, 2006.
48. Grayson, A. C., G. Voskerician, A. Lynn, J. M. Anderson, M. J. Cima, and R. Langer. Differential degradation rates in vivo and in vitro of biocompatible poly(lactic acid) and poly(glycolic acid) homo- and co-polymers for a polymeric drug-delivery microchip. J. Biomater. Sci. Polym. Ed. 15:1281-1304, 2004.
49. Grossman, H. B., M. Soloway, E. Messing, G. Katz, B. Stein, V. Kassabian, and Y. Shen. Surveillance for recurrent bladder cancer using a point-of-care proteomic assay. JAMA 295:299-305, 2006.
50. Hammermeister, K., G. K. Sethi, W. G. Henderson, F. L. Grover, C. Oprian, and S. H. Rahimtoola. Outcomes 15 years after valve replacement with a mechanical versus a bioprosthetic valve: final report of the Veterans Affairs randomized trial. J. Am. Coll. Cardiol. 36:1152-1158, 2000.
51. Hill, J. M., A. J. Dick, V. K. Raman, R. B. Thompson, Z. X. Yu, K. A. Hinds, B. S. Pessanha, M. A. Guttman, T. R. Varney, B. J. Martin, C. E. Dunbar, E. R. McVeigh, and R. J. Lederman. Serial cardiac magnetic resonance imaging of injected mesenchymal stem cells. Circulation 108:1009-1014, 2003.
52. Hoerstrup, S. P., R. Sodian, S. Daebritz, J. Wang, E. A. Bacha, D. P. Martin, A. M. Moran, K. J. Guleserian, J. S. Sperling, S. Kaushal, J. P. Vacanti, F. J. Schoen, and J. E. Mayer. Functional living trileaflet heart valves grown in vitro. Circulation 102:SIII-44-SIII-49, 2000.
53. Hollister, S. J. Porous scaffold design for tissue engineering. Nat. Mater. 4:518-524, 2005.
54. Hopkins, R. A. Tissue engineering of heart valves: decellularized valve scaffolds. Circulation 111:2712-2714, 2005.
55. Hoque, M. O., O. Topaloglu, S. Begum, R. Henrique, E. Rosenbaum, W. Van Criekinge, W. H. Westra, and D. Sidransky. Quantitative methylation-specific polymerase chain reaction gene patterns in urine sediment distinguish prostate cancer patients from control subjects. J. Clin. Oncol. 23:6569-6575, 2005.
56. Hristov, M., W. Erl, and P. C. Weber. Endothelial progenitor cells: mobilization, differentiation, and homing. Arterioscler. Thromb. Vasc. Biol. 23:1185-1189, 2003.
57. Ichikawa, T., D. Hogemann, Y. Saeki, E. Tyminski, K. Terada, R. Weissleder, E. A. Chiocca, and J. P. Basilion. MRI of transgene expression: correlation to therapeutic gene expression. Neoplasia 4:523-530, 2002.
58. Isenberg, B. C., C. Williams, and R. T. Tranquillo. Small-diameter artificial arteries engineered in vitro. Circ. Res. 98:25-35, 2006.
59. Ishihara, T., V. J. Ferrans, M. Jones, S. W. Boyce, and W. C. Roberts. Occurrence and significance of endothelial cells in implanted porcine bioprosthetic valves. Am., J. Cardiol. 48:443-454, 1981.
60. Iwai, S., Y. Sawa, H. Ichikawa, S. Taketani, E. Uchimura, G. Chen, M. Kara, J. Miyake, and H. Matsuda. Biodegradable polymer with collagen microsponge serves as a new bioengineered cardiovascular prosthesis. J. Thorac. Cardiovasc. Surg. 128:472-479, 2004.
61. Iwami, Y., H. Masuda, and T. Asahara. Endothelial progenitor cells: past, state of the art, and future. J. Cell Mol. Med. 8:488-497, 2004.
62. Jaffer, F. A., and R. Weissleder. Seeing within: molecular imaging of the cardiovascular system. Circ. Res. 94:433-445, 2004.
63. Jaffer, F. A., and R. Weissleder. Molecular imaging in the clinical arena. J. Am. Med. Assoc. 293:855-862, 2005.
64. Jamieson, W. R., O. von Lipinski, R. T. Miyagishima, L. H. Burr, M. T. Janusz, H. Ling, G. J. Fradet, F. Chan, and E. Germann. Performance of bioprostheses and mechanical prostheses assessed by composites of valve-related complications to 15 years after mitral valve replacement. J. Thorac. Cardiovasc. Surg. 129:1301-1308, 2005.
65. Jiang, Y., B. N. Jahagirdar, R. L. Reinhardt, R. E. Schwanz, C. D. Keene, X. R. Ortiz-Gonzalez, M. Reyes, T. Lenvik, T. Lund, M. Blackstad, J. Du, S. Aldrich, A. Lisberg, W. C. Low, D. A. Largaespada, and C. M. Verfaillie. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418:41-49, 2002.
66. Jockenhoevel, S., G. Zund, S. P. Hoerstrup, K. Chalabi, J. S. Sachweh, L. Demircan, B. J. Messmer, and M. Turina. Fibrin gel - advantages of a new scaffold in cardiovascular tissue engineering. Eur. J. Cardiothorac. Surg. 19:424-430, 2001.
67. Jonas, R. A. The Ross procedure is not the procedure of choice for the teenager requiring aortic valve replacement. Semin. Thorac. Cardiovasc. Surg. Pediatr. Card Surg. Annu. 176-180, 2005.
68. Kanter, K. R., J. M. Budde, W. J. Parks, V. K. Tam, S. Sharma, W. H. Williams, and D. A. Fyfe. One hundred pulmonary valve replacements in children after relief of right ventricular outflow tract obstruction. Ann. Thorac. Surg. 73:1801-1806, 2002.
69. Karageorgiou, V. and D. Kaplan. Porosity of 3D biomaterial scaffolds and osteogenesis. Biomaterials 26:5474-5491, 2005.
70. Kaushal, S., G. E. Amiel, K. J. Guleserian, O. M. Shapira, T. Perry, F. W. Sutherland, E. Rabkin, A. M. Moran, F. J. Schoen, A. Atala, S. Soker, J. Bischoff, and J. E. Mayer. Functional small-diameter neovessels created using endothelial progenitor cells expanded ex vivo. Nature Med. 7:1035-1040, 2001.
71. Kohn, J., S. Abramson, and R. Langer. Bioresorbable and bioerodible materials. In: Biomaterials Science: An Introduction to Materials in Medicine, 2nd Ed., edited by B. D. Ratner, A. S. Hoffman, F. J. Schoen, and J. E. Lemons. Orlando: Academic Press, 2004.
72. Konertz, W., P. M. Dohmen, J. Liu, S. Beholz, S. Dushe, S. Posner, A. Lembcke, and W. Erdbrugger. Hemodynamic characteristics of the Matrix P decellularized xenograft for pulmonary valve replacement during the Ross operation. J. Heart Valve Dis. 14:78-81, 2005.
73. Kumar, V., N. Fausto, and A. Abbas. Robbins and Cotran Pathologic Basis of Disease, 7th Ed. Philadelphia: W. B. Saunders, 2004.
74. Laflamme, M. A., and C. E. Murry. Regenerating the heart. Nature Biotech. 23:845-855, 2005.
75. Lahann, J., S. Mitragotri, T. N. Tran, H. Kaido, J. Sundaram, I. S. Choi, S. Hoffer, G. A. Somorjai, and R. Langer. A reversibly switching surface. Science 299:371-374, 2003.
76. Langer, R., and D. A. Tirrell. Designing materials for biology and medicine. Nature 428:487-492, 2004.
77. Langer, R., and J. P. Vacanti. Tissue engineering. Science 260:920-926, 1993.
78. Lee, Y. M., J. J. Cope, G. E. Ackermann, K. Goishi, E. J. Armstrong, B. H. Paw, and J. Bischoff. Vascular endothelial growth factor receptor signaling is required for cardiac valve formation in zebrafish. Dev. Dyn. 235:29-37, 2006.
79. Lendlein, A., and R. Langer. Biodegradable, elastic shape-memory polymers for potential biomedical applications. Science 296:1673-1676, 2002.
80. Leor, J., Y. Amsalem, and S. Cohen. Cells, scaffolds, and molecules for myocardial tissue engineering. Pharmacol. Therapeut. 105:151-163, 2005.
81. Leri, A., J. Kajstura, and P. Anversa. Cardiac stem cells and mechanisms of myocardial regeneration. Physiol. Rev. 85:1373-1416, 2005.
82. Liu, C., K. A. Nath, Z. S. Katusic, and N. M. Caplice. Smooth muscle progenitor cells in vascular disease. Trends Cardiovasc. Med. 14:288-293, 2004.
83. Liu, X., and P. X. Ma. Polymeric scaffolds for bone tissue engineering. Ann. Biomed. Eng. 32:477-486, 2004.
84. Lutolf, M. P., and J. A. Hubbell. Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering. Nat. Biotechnol. 23:47-55, 2005.
85. Mann, B. K., A. S. Gobin, A. T. Tsai, R. H. Schmedlen, and J. L. West. Smooth muscle cell growth in photopolymerized hydrogels with cell adhesive and proteolytically degradable domains: synthetic ECM analogs for tissue engineering. Biomaterials 22:3045-3051, 2001.
86. Mareschi, K., I. Ferrero, D. Rustichelli, S. Aschero, L. Gammaitoni, M. Aglietta, E. Madon, and F. Fagioli. Expansion of mesenchymal stem cells isolated from pediatric and adult donor bone marrow. J. Cell Biochem. 97:744-754, 2006.
87. Marron, K., M. H. Yacoub, J. M. Polak, M. N. Sheppard, D. Fagan, B. F. Whitehead, M. R. de Leval, R. H. Anderson, and J. Wharton. Innervation of human atrioventricular and arterial valves. Circulation 94:368-375, 1996.
88. Masters, K. S., D. N. Shah, L. A. Leinwand, and K. S. Anseth. Crosslinked hyaluronan scaffolds as a biologically active carrier for valvular interstitial cells. Biomaterials 26:2517-2525, 2005.
89. Matheny, R. G., M. L. Hutchison, P. E. Dryden, M. D. Hiles, and C. J. Shaar. Porcine small intestine submucosa as a pulmonary valve leaflet substitute. J. Heart Valve Dis. 9:769-774, 2000.
90. Mauney, J. R., V. Volloch, and D. L. Kaplan. Role of adult mesenchymal stem cells in bone tissue engineering applications: current status and future prospects. Tissue Eng. 11:787-802, 2005.
91. McBrearty, B. A., L. D. Clark, X-M, Zhang, E. P. Blankenhorn, and E. Heber-Katz. Genetic analysis of a mammalian wound-healing trait. Proc. Natl. Acad. Sci. USA 95:11792-11797, 1998.
92. Merryman, W. D., G. C. Engelmayr, J. Liao, and M. S. Sacks. Defining biomechanical endpoints for tissue engineered heart valve leaflets from native leaflet properties. Prog. Ped. Card. (in press).
93. Merryman, W. D., H. D. Lukoff, R. A. Hopkins, and M. S. Sacks. Aortic valve interstitial cell phenotype and biosynthesis: synergistic effects of cyclic tension and TGF-β1. Proceedings of BIO2006. ASME Summer Bioengineering Conference, 2006.
94. Merryman, W. D., I. Youn, H. D. Lukoff, P. M. Krueger, F. Guilak, R. A. Hopkins, and M. S. Sacks. Correlation between heart valve interstitial cell stiffness and transvalvular pressure: implications for collagen biosynthesis. Am. J. Physiol. Heart Circ. Physiol. 290:H224-H231, 2006.
95. Mitchell, R. N., R. A. Jonas, and F. J. Schoen. Pathology of explanted cryopreserved allograft heart valves: comparison with aortic valves from orthotopic heart transplants. J. Thorac. Cardiovasc. Surg. 115:118-127, 1998.
96. Mol, A., N. J. Driessen, M. C. Rutten, S. P. Hoerstrup, C. V. Bouten, and F. P. Baaijens. Tissue engineering of human heart valve leaflets: a novel bioreactor for a strain-based conditioning approach. Ann. Biomed. Eng. 33:1778-1788, 2005.
97. Mol, A., M. I. van Lieshout, C. G. Dam-de Veen, S. Neuenschwander, S. P. Hoerstrup, F. P. Baaijens, and C. V. Bouten. Fibrin as a cell carrier in cardiovascular tissue engineering applications. Biomaterials 26:3113-3121, 2005.
98. Mouquet, F., O. Pfister, M. Jain, A. Oikonomopoulos, S. Ngoy, R. Summer, A. Fine, and R. Liao. Restoration of cardiac progenitor cells after myocardial infarction by self-proliferation and selective homing of bone marrow-derived stem cells. Circ Res. 97:1090-1092, 2005.
99. Mulholland, D. L., and A. I. Gotlieb. Cell biology of valvular interstitial cells. Can. J. Cardiol. 12:231-236, 1996.
100. Muschler, G. F., C. Nakamoto, and L. G. Griffith. Engineering principles of clinical cell-based tissue engineering., J. Bone Joint Surg. Am. 86A: 1541-1558, 2004.
101. Narita, Y., K. Hata, H. Kagami, A. Usui, M. Ueda, and Y. Ueda. Novel pulse duplicating bioreactor system for tissue-engineered vascular construct. Tissue Eng. 10:1224-1233, 2004.
102. Nerem, R. M., and A. E. Ensley. The tissue engineering of blood vessels and the heart. Am. J. Transplant 4:36-42, 2004.
103. Niklason, L. E., J. Gao, W. M. Abbott, K. K. Hirschi, S. Houser, R. Marini, and R. Langer. Functional arteries grown in vitro. Science 284:489-493, 1999.
104. Nugent, H. M., and E. R. Edelman. Tissue engineering therapy for cardiovascular disease. Circ. Res. 92:1068-1078, 2003.
105. Ogata, T., H. Shibamura, G. Tromp, M. Sinha, K. A. Goddard, N. Sakalihasan, R. Limet, G. L. MacKean, C. Arthur, T. Sueda, S. Land, and H. Kuivaniemi. Genetic analysis of polymorphisms in biologically relevant candidate genes in patients with abdominal aortic aneurysms. J. Vasc. Surg. 41:1036-1042, 2005.
106. Olson, E. N. A decade of discoveries in cardiac biology. Nat. Med. 10:467-474, 2004.
107. Orlic, D., J. Kajstura, S. Chimenti, F. Limana, I. Jakoniuk, F. Quaini, B. Nadal-Ginard, D. M. Bodine, A. Leri, and P. Anversa. Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc. Natl. Acad. Sci. 98:10344-10349, 2001.
108. Ota, T., Y. Sawa, S. Iwai, T. Kitajima, Y. Ueda, C. Coppin, H. Matsuda, and Y. Okita. Fibronectin-hepatocyte growth factor enhances reendothelialization in tissue-engineered heart valve. Ann. Thorac. Surg. 80:1794-1801, 2005.
109. Ott, I., U. Keller, M. Knoedler, K. S. Götze, K. Doss, P. Fischer, K. Urlbauer, G. Debus, N. von Bubnoff, M. Rudelius, A. Schomig, C. Peschel, and R. A. Oostendorp. Endothelial-like cells expanded from CD34 + blood cells improve left ventricular function after experimental myocardial infarction. FASEB 19:992-994, 2005.
110. Paranya, G., S. Vineberg, E. Dvorin, S. Kaushal, S. J. Roth, E. Rabkin, F. J. Schoen, and J. Bischoff. Aortic valve endothelial cells undergo TGF-beta-mediated and non-TGF-beta-mediated transdifferentiation in vitro. Am. J. Pathol. 159:1335-1343, 2001.
111. Patel, N. A., D. L. Stamper, and M. E. Brezinski. Review of the ability of optical coherence tomography to characterize plaque, including a comparison with intravascular ultrasound. Cardiovasc. Intervent. Radial. 28:1-9, 2005.
112. Perry, T. E., S. Kaushal, F. W. Sutherland, K. J. Guleserian, J. Bischoff, M. Sacks, and J. E. Mayer. Bone marrow as a cell source for tissue engineering heart valves. Ann. Thorac. Surg. 75:761-767, 2003.
113. Pittenger, M. F., and B. J. Martin. Mesenchymal stem cells and their potential as cardiac therapeutics. Circ. Res. 95:9-20, 2004.
114. Poh, M., M. Boyer, A. Solan, S. L. Dahl, D. Pedrotty, S. S. Banik, J. A. McKee, R. Y. Klinger, C. M. Counter, and L. E. Niklason. Blood vessels engineered from human cells. Lancet 365:2122-2124, 2005.
115. Pratt, A. B., F. E. Weber, H. G. Schmoekel, R. Muller, and J. A. Hubbell. Synthetic extracellular matrices for in situ tissue engineering. Biotechnol. Bioeng. 86:27-36, 2004.
116. Prockop, D. J. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 276:71-74, 1997.
117. Rabkin, E., M. Aikawa, J. R. Stone, Y. Fukumoto, P. Libby, and F. J. Schoen. Activated interstitial myofibroblasts express catabolic enzymes and mediate matrix remodeling in myxomatous heart valves. Circulation 104:2525-2532, 2001.
118. Rabkin, E., S. P. Hoerstrup, M. Aikawa, J. E. Mayer, and F. J. Schoen. Evolution of cell phenotype and extracellular matrix in tissue-engineered heart valves during in vitro maturation and in vivo remodeling. J. Heart Valve Dis. 11:308-314, 2002.
119. Rabkin, E., and F. J. Schoen. Cardiovascular tissue engineering. Cardiovasc. Pathol. 11:305-317, 2002.
120. Rabkin-Aikawa, E., M. Aikawa, M. Farber, J. R. Kratz, G. Garcia-Cardena, N. T. Kouchoukos, M. B. Mitchell, R. A. Jonas, and F. J. Schoen. Clinical pulmonary autograft valves: pathologic evidence of adaptive remodeling in the aortic site. J. Thorac. Cardiovasc. Surg. 128:552-561, 2004.
121. Rabkin-Aikawa, E., M. Farber, M. Aikawa, and F. J. Schoen. Dynamic and reversible changes of interstitial cell phenotype during remodeling of cardiac valves. J. Heart Valve Dis. 13:841-847, 2004.
122. Rabkin-Aikawa, E., J. E. Mayer, and F. J. Schoen. Heart valve regeneration. Adv. Biochem. Eng. Biotechnol. 94:141-179, 2005.
123. Radisic, M., H. Park, H. Shing, T. Consi, F. J. Schoen, R. Langer, L. E. Freed, and G. Vunjak-Novakovic. Functional assembly of engineered myocardium by electrical stimulation of cardiac myocytes cultured on scaffolds. Proc. Natl. Acad. Sci. USA 101:18129-18134, 2004.
124. Radisky, D. C. Epithelial-mesenchymal transition. J. Cell Sci. 118:4325-4326, 2005.
125. Rafii, S., and D. Lyden. Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat. Med. 9:702-712, 2003.
126. Rafii, S., M. C. Oz, J. A. Seldomridge, B. Ferris, A. S. Asch, R. L. Nachman, F. Shapiro, E. A. Rose, and H. R. Levin. Characterization of hematopoietic cells arising on the textured surface of left ventricular assist devices. Ann. Thorac. Surg. 60:1627-1632, 1995.
127. Rahimtoola, S. H. Choice of prosthetic heart valve for adult patients. J. Am. Coll. Cardiol. 41:893-904, 2003.
128. Rahimtoola, S. H. The next generation of prosthetic heart valves needs a proven track record of patient outcomes at > or =15 to 20 years. J. Am. Coll. Cardiol. 42:1720-1721, 2003.
129. Ramamurthi, A., and I. Vesely. Evaluation of the matrix-synthesis potential of crosslinked hyaluronan gels for tissue engineering of aortic heart valves. Biomaterials 26:999-1010, 2005.
130. Ratner, B. D., and S. J. Bryant. Biomaterials: Where we have been and where we are going. Ann. Rev. Biomed. Eng. 6:41-75, 2004.
131. Rieder, E., G. Seebacher, M. Kasimir, E. Eichmair, B. Winter, B. Dekan, E. Wolner, P. Simon, and G. Weigel. Tissue engineering of heart valves: decellularized porcine and human valve scaffolds differ importantly in residual potential to attract monocytic cells. Circulation 111:2792-2797, 2005.
132. Robinson, K. A., J. Li, M. Mathison, A. Redkar, J. Cui, N. A. Chronos, R. G. Matheny, and S. F. Badylak. Extracellular matrix scaffold for cardiac repair. Circulation 112:1135-1143, 2005.
133. Roeder, R. A., G. C. Lantz, and L. A. Geddes. Mechanical remodeling of small-intestine submucosa small-diameter vascular grafts - A preliminary report. Biomed. Instrum. Technol. 35:110-120, 2001.
134. Ross, J. J., and R. T. Tranquillo. ECM gene expression correlates with in vitro tissue growth and development in fibrin gel remodeled by neonatal smooth muscle cells. Matrix Biol. 22:477-490, 2003.
135. Rossig, L., C. Urbich, and S. Dimmeler. Endothelial progenitor cells at work. Not mature yet, but already stress-resistant. Arterioscler. Thromb. Vasc. Biol. 24:1977-1979.
136. Roy, R., U. M. Wewer, D. Zurakowski, S. E. Pories, and M. A. Moses. ADAM 12 cleaves extracellular matrix proteins and correlates with cancer status and stage. J. Biol. Chem. 279:51323-51330, 2004.
137. Saiura, A., M. Sata, Y. Hirata, R. Nagai, and M. Makuuchi. Circulating smooth muscle progenitor cells contribute to atherosclerosis. Nat. Med. 7:382-383, 2001.
138. Sata, M., Fukuda, D., Tanaka, K., Kaneda, Y., Yashiro, H., and I. Shirakawa. The role of circulating precursors in vascular repair and lesion formation. J. Cell Mol. Med. 9:557-568, 2005.
139. Sata, M., A. Saiura, A. Kunisato, A. Tojo, S. Okada, T. Tokuhisa, H. Hirai, M. Makuuchi, Y. Hirata, and R. Nagai. Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis. Nat. Med. 8:403-409, 2002.
140. Sayk, F., I. Bos, U. Schubert, T. Wedel, and H. H. Sievers. Histopathologic findings in a novel decellularized pulmonary homograft: an autopsy study. Ann. Thorac. Surg. 79:1755-1758, 2005.
141. Schenke-Layland, K., I. Riemann, F. Opitz, K. Konig, K. J. Halbhuber, and U. A. Stock. Comparative study of cellular and extracellular matrix composition of native and tissue engineered heart valves. Matrix Biol. 23:113-125, 2004.
142. Schmitt-Graff, A., A. Desmouliere, and G. Gabbiani. Heterogeneity of myofibroblast phenotypic features: an example of fibroblastic cell plasticity. Virchows Arch. 425:3-24, 1994.
143. Schoen, F. J. Aortic valve structure-function correlations: role of elastic fibers no longer a stretch of the imagination. J. Heart Valve Dis. 6:1-6, 1997.
144. Schoen, F. J., S. H. Goodenough, M. I. Ionescu, and N. S. Braunwald. Implications of late morphology of Braunwald-Cutter mitral heart valve prostheses. J. Thorac. Cardiovasc. Surg. 88:208-216, 1984.
145. Schoen, F. J. Future directions in tissue heart valves: Impact of recent insights from biology and pathology. J. Heart Valve Dis. 8:350-358, 1999.
146. Schoen, F. J. Pathology of heart valve substitution with mechanical and tissue prostheses. In: Cardiovascular Pathology 3rd Ed., edited by M. D. Silver, A. I. Gotlieb, and F. J. Schoen. New York: Churchill Livingstone, 2001, pp. 629-677.
147. Schoen, F. J., and W. D. Edwards. Valvular heart disease: General principles and stenosis. In: Cardiovascular Pathology 3rd Ed., edited by M. D. Silver, A. I. Gotlieb, and F. J. Schoen. New York: Churchill Livingstone, 2001, pp. 402-405.
148. Schurch, W., T. A. Seemayer, and G. Gabbiani. The myofibroblast: a quarter century after its discovery. Am. J. Surg. Pathol. 22:141-147, 1998.
149. Shi, Q., S. Rafii, M. H. Wu, E. S. Wijelath, C. Yu, A. Ishida, Y. Fujita, S. Kothari, R. Mohle, L. R. Sauvage, M. A. Moore, R. F. Storb, and W. P. Hammond. Evidence for circulating bone marrow-derived endothelial cells. Blood 92:362-367, 1998.
150. Shi, Y., A. Ramamurthi, and I. Vesely. Towards tissue engineering of a composite aortic valve. Biomed. Sci. Iustrum. 38:35-40, 2002.
151. Shi, Y., and I. Vesely. Fabrication of mitral valve chordae by directed collagen gel shrinkage. Tissue Eng. 9:1233-1242, 2003.
152. Shinoka, T., C. K. Breuer, R. E. Tanel, G. Zund, T. Miura, P. X. Ma, R. Langer, J. P. Vacanti, and J. E. Mayer. Tissue engineering heart valves: valve leaflet replacement study in a lamb model. Aim. Thorac. Surg. 60:8513-8516, 1995.
153. Shinoka, T., P. X. Ma, D. Shum-Tim, C. K. Breuer, R. A. Cusick, G. Zund, R. Langer, J. P. Vacanti, and J. E. Mayer. Tissue-engineered heart valves. Autologous valve leaflet replacement study in a lamb model. Circulation 94:11164-11168, 1996.
154. Silva, G. A., C. Czeisler, K. L. Niece, E. Beniash, D. A. Harrington, J. A. Kessler, and S. I. Stupp. Selective differentiation of neural progenitor cells by high-epitope density nanofibers. Science 303:1352-1355, 2004.
155. Simmons, C. A., G. R. Grant, E. Manduchi, and P. F. Davies. Spatial heterogeneity of endothelial phenotypes correlates with side-specific vulnerability to calcification in normal porcine aortic valves. Circ. Res. 96:792-799, 2005.
156. Simon, P., M. T. Kasimir, G. Seebacher, G. Weigel, R. Ullrich, U. Salzer-Muhar, E. Rieder, and E. Wolner. Early failure of the tissue engineered porcine heart valve SYNERGRAFT in pediatric patients. Eur. J. Cardiothorac. Surg. 23:1002-1006, 2003.
157. Simper, D., P. G. Stalboerger, C. J. Panetta, S. Wang, and N. M. Caplice. Smooth muscle progenitor cells in human blood. Circulation 106:1199-1204, 2002.
158. Sodian, R., T. Lemke, C. Fritsche, S. P. Hoerstrup, P. Fu, E. V. Potapov, H. Hausmann, and R. Hetzer. Tissue-engineering bioreactors: a new combined cell-seeding and perfusion system for vascular tissue engineering. Tissue Eng. 8:863-870, 2002.
159. Spina, M., F. Ortolani, A. E. Messlemani, A. Gandaglia, J. Bujan, N. Garcia-Honduvilla, I. Vesely, G. Gerosa, D. Casarotto, L. Petrelli, and M. Marchini. Isolation of intact aortic valve scaffolds for heart-valve bioprostheses: extracellular matrix structure, prevention from calcification, and cell repopulation features. J. Biomed. Mater. Res. 67:1338-1350, 2003.
160. Srivastava, D., and E. N. Olson. A genetic blueprint for cardiac development. Nature 407:221-226, 2000.
161. Stegemann, J. P., and R. M. Nerem. Phenotype modulation in vascular tissue engineering using biochemical and mechanical stimulation. Ann. Biomed. Eng. 31:391-402, 2003.
162. Steinhoff, G., U. Stock, N. Karim, H. Mertsching, A. Timke, R. Meliss, K.
163. Stock, U. A., and K. Schenke-Layland. Performance of decellularized xenogeneic tissue in heart valve replacement. Biomateriah 21:1-2, 2006.
164. Sutherland, F. W. H., T. E. Perry, Y. Yu, M. C. Sherwood, E. Rabkin, Y. Masuda, G. A. Garcia, D. L. McLellan, G. C. Engelmayr, M. S. Sacks, F. J. Schoen, and J. E. Mayer. From stem cells to viable autologous semilunar heart valves. Circulation 111:2783-2791, 2005.
165. Szmitko, P. E., P. W. Fedak, R. D. Weisel, D. J. Stewart, M. J. Kutryk, and S. Verma. Endothelial progenitor cells: new hope for a broken heart. Circulation 107:3093-3100, 2003.
166. Tamariz, E., and F. Grinnell. Modulation of fibroblast morphology and adhesion during collagen matrix remodeling. Mol. Biol. Cell 13:3915-3929, 2002.
167. Tanaka, K., M. Sata, D. Fukuda, Y. Suematsu, N. Motomura, S. Takamoto, Y. Hirata, and R. Nagai. Age-associated aortic stenosis in apolipoprotein E-deficient mice. J. Am. Coll. Cardiol. 46:134-141, 2005.
168. Taylor, P. M., S. P. Allen, and M. H. Yacoub. Phenotypic and functional characterization of interstitial cells from human heart valves, pericardium and skin. J. Heart Valve Dis. 9:150-158, 2000.
169. Taylor, P. M., P. Batten, N. J. Brand, P. S. Thomas, and M. H. Yacoub. The cardiac valve interstitial cell. Int. J. Biochem. Cell. Biol. 35:113-118, 2003.
170. Tranquillo, R. T., M. A. Durrani, and A. G. Moon. Tissue engineering science: consequences of cell traction force. Cytotechnology 10:225-250, 1992.
171. Tranquillo, R., T. Girton, and M. Neidert. Tissue Equivalent Approach to a Tissue Engineered Cardiovascular Valve. Minneapolis: Regents of the University of Minnesota; 2003.
172. Urbich, C., A. Aicher, C. Heeschen, E. Dernbach, W. K. Hofmann, A. M. Zeiher, and S. Dimmeler. Soluble factors released by endothelial progenitor cells promote migration of endothelial cells and cardiac resident progenitor cells. J. Mol. Cell Cardiol. 39:733-742, 2005.
173. Urbich, C., and S. Dimmeler. Endothelial progenitor cells: characterization and role in vascular biology. Circ.Res. 95:343-353, 2004.
174. Van den Hoff, M. J., B. P. Kruithof, A. F. Moorman, R. R. Markwald, and A. Wessels. Formation of myocardium after the initial development of the linear heart tube. Dev. Biol. 240:61-76, 2001.
175. Van Le, T. S., R. Miller, T. Barder, M. Babjuk, D. M. Potter, and R. H. Getzenberg. Highly specific urine-based marker of bladder cancer. Urology 66:1256-1260, 2005.
176. Vesely, I. Heart valve tissue engineering. Circ. Res. 97:743-755, 2005.
177. Walker, G. A., K. S. Masters, D. N. Shah, K. S. Anseth, and L. A. Leinwand. Valvular myofibroblast activation by transforming growth factor-beta: implications for pathological extracellular matrix remodeling in heart valve disease. Circ. Res. 95:253-260, 2004.
178. Weinberg, C. B., and E. Bell. A blood vessel model constructed from collagen and cultured vascular cells. Science 231:397-400, 1986.
179. Weinshilboum, R. Inheritance and drug response. N. Engl. J. Med. 348:529-537, 2003.
180. Werner, N., S. Kosiol, T. Schiegl, P. Ahlers, K. Walenta, A. Link, M. Bohm, and G. Nickenig. Circulating endothelial progenitor cells and cardiovascular outcomes. N. Engl. J. Med. 353:999-1007, 2005.
181. Williams, C., and T. M. Wick. Perfusion bioreactor for small diameter tissue-engineered arteries. Tissue Eng. 10:930-941, 2004.
182. Wood, J. D., A. Simmons-Byrd, A. R. Spievack, and S. F. Badylak. Use of a particulate extracellular matrix bioscaffold for treatment of acquired urinary incontinence in dogs. J. Am. Vet. Med. Assoc. 226:1095-1097, 2005.
183. Wu, X., L. Huang, Q. Zhou, Y. Song, A. Li, J. Jin, and B. Cui. Mesenchymal stem cells participating in ex vivo endothelium repair and its effect on vascular smooth muscle cells growth. Int. J. Cardiol. 105:274-282, 2005.
184. Wu, X., E. Rabkin-Aikawa, K. J. Guleserian, T. E. Perry, Y. Masuda, F. W. Sutherland, F. J. Schoen, J. E. Mayer, and J. Bischoff. Tissue-engineered microvessels on three-dimensional biodegradable scaffolds using human endothelial progenitor cells. Am. J. Physiol. Heart Circ. Physiol. 287:H480-H487, 2004.
185. Yacoub, M. H., and L. H. Cohn. Novel approaches to cardiac valve repair: from structure to function: Part I. Circulation 109:942-950, 2004.
186. Yang, J., M. Yamato, C. Kohno, A. Nishimoto, H. Sekine, F. Fukai, and T. Okano. Cell sheet engineering: recreating tissues without biodegradable scaffolds. Biomaterials 26:6415-6422, 2005.
187. Ye, Q., G. Zund, P. Benedikt, S. Jockenhoevel, S. P. Hoerstrup, S. Sakyama, J. A. Hubbell, and M. Turina. Fibrin gel as a three dimensional matrix in cardiovascular tissue engineering. Eur. J. Cardiothorac. Surg. 17:587-591, 2000.
188. Zund, G., C. K. Breuer, T. Shinoka, P. X. Ma, R. Langer, J. E. Mayer, and J. P. Vacanti. The in vitro construction of a tissue engineered bioprosthetic heart valve. Eur. J. Cardiothorac. Surg. 11:493-497, 1997.